Cita APA (7a ed.)

Y, K., Y, K., Y, M., T, S., S, N., M, M., . . . A, G. (2021). Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report. Dove Medical Press.

Cita Chicago Style (17a ed.)

Y, Kato, et al. Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report. Dove Medical Press, 2021.

Cita MLA (8a ed.)

Y, Kato, et al. Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report. Dove Medical Press, 2021.